Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Sequent Scientific Limited ( (IN:SEQUENT) ) is now available.
Sequent Scientific Limited has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, in two newspapers, The Financial Express and Nava Telangana. This announcement is part of the company’s compliance with regulatory requirements, providing stakeholders with insights into its financial performance for the specified period.
More about Sequent Scientific Limited
Sequent Scientific Limited operates in the life sciences industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its expertise in the life sciences sector and serves various markets with its pharmaceutical offerings.
Average Trading Volume: 67,477
Technical Sentiment Signal: Buy
Current Market Cap: 42.12B INR
Learn more about SEQUENT stock on TipRanks’ Stock Analysis page.

